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Adult acquired pancreatic
diseasesAbstract Background: It is usually hard to detect pancreatic lesions early as the pancreas lays
retro peritoneum so it cannot be assessed during a routine physical exam. By the time a person
has symptoms, the disease has already established morphological imaging CT changes.
Objective: The objective of our study was to clarify the role of multidetector computerized
tomography (MDCT) in different adult acquired pancreatic diseases and assess the efﬁcacy of
surgical pancreatic tumors resectability preoperative.
Materials & methods: The study included thirty adult patients suspected to have pancreatic diseases
(18 males and 12 females); their age range was 45–90 years with a mean age of 68 years. All patients
underwent triple-phase multi-detector row CT using a 16-slice machine. The presence of
inﬂammation, masses, and vascular invasion was evaluated and interpreted images were obtained
during each phase. Results were compared with surgery, histopathology or follow-up.
Results: Of 30 patients, 15 had pancreatic malignancies (14 adenocarcinoma of which 6 were
resectable and 8 were irresectable, 1 distant metastasis) proven at biopsy and/or surgery, 11 patients
had pancreatitis (acute and chronic), three patients had cystic benign tumors (2 mucinous cystade-
noma, 1 serous cystadenoma), and one patient had neuroendocrine tumor (insulinoma).
Conclusion: Contrast enhanced multiphase pancreatic imaging by MDCT with its post processing
techniques represents the imaging modality of choice for the diagnosis of different adult acquired
pancreatic diseases.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Imaging of the pancreas is a challenging investigation because of
its anatomic location in the retro peritoneum and its intricaterelationship with major blood vessels and bowel. CT had been
the initial imaging modality of choice for evaluation of pancre-
atic pathology. Improvements in CT technology during the past
decade, with fast image acquisition and improved spatial resolu-
tion, had increased the accuracy of CT lesion detection and
characterization. Excellent visualization of the pancreatic par-
enchyma in various phases of contrast enhancement facilitates
Table 1 MDCT diagnosis in relation to the number of
patients.
MDCT diagnosis Number of
patients
Percentage
(%)
Acute pancreatitis 8 26.6
Chronic pancreatitis 3 10
Adenocarcinoma 14 46.6
Neuroendocrine tumor
(insulinoma)
1 3.3
Cystic pancreatic tumors 3 10
Metastasis 1 3.3
Table 2 The age range distribution in the 30 included
patients.
Age range Number of patients
45–55 13
56–65 10
66–75 6
>75 1 (90y)
30
8 M.Y. Tadros, R.Z. Eliaearly detection of small pancreatic lesions. Post processing
techniques provide a vascular road map for the operating
surgeon.1
Acute pancreatitis is a disease with a broad spectrum of
ﬁndings that varies in severity from mild interstitial or
edematous pancreas to severe form with signiﬁcant local and
systemic complications that are associated with a substantial
degree of morbidity and mortality.2
Contrast enhanced computed tomography (CECT) is useful
in determining the underlying cause of pancreatitis, grading
the severity and detection of local complications such as
necrosis, abscess, or pseudo cysts.3
CT outclasses all imaging modalities in detecting
calciﬁcations, any speciﬁc sign of advanced chronic pancreati-
tis. CT can also detect most complications such as pseudocysts,
calculi in the pancreatic duct or inﬂammatory masses.4
Pancreatic cancer is one of the most lethal diseases, with a
poor prognosis. Surgical resection remains the only potentially
curative treatment. Therefore, accurate staging to select
patients who may beneﬁt from resection is essential. In patients
with resectable tumors, accurate diagnoses of tumor extension,
vessel involvement, and the presence or absence of liver
metastasis are necessary before operation.5
The latest multi-detector computed tomography (MDCT)
technology provides three-dimensional multi-planar
reconstruction techniques enabling determination of tumor
involvement of the common bile duct (CBD), pancreatic duct,
and peripancreatic vasculature, which is expected to improve
the preoperative determination of surgical resectability,
particularly in relation to vascular invasion.6
2. Materials & methods
2.1. Subjects
This study was conducted on 30 selected patients (18 males and
12 females) suspected on clinical symptoms (Fig. 1) and
laboratory ﬁndings of having different acquired pancreatic
diseases listed in Table 1. The age range distribution among
the examined patients is demonstrated in Table 2. The mean
age of patients was 68 years.
Study was conducted in some private radiology centers and
in Ain Shams Specialized Hospital starting from January 2012
to May 2015. Patients’ Exclusion criteria included patients0 
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Figure 1 The clinical presentation of patients.with congenital pancreatic disease, contraindication to iodi-
nated contrast media (chronic renal impairment or previous
allergy to the contrast media), and pregnant women. An
informed consent was obtained from all patients after full
explanation of the beneﬁts and risks of this procedure.
2.2. Methods
All patients were subjected to careful history taking, general
and abdominal examination, laboratory and serological
examinations, abdomino-pelvic ultrasound and multi-
detector computed tomography.
This study was performed using a 16 slice multi-detector
CT (Toshiba activeon). Patients fasted for about 4–6 h before
examination. Reassurance and brief explanation of the proce-
dure was done. All patients were examined in supine position,
each patient was instructed to remain stable and suspend
breathing during scanning time.
Opaciﬁcation of the gastrointestinal tract with oral contrast
material was done before CT scanning using one liter of
diluted 2–4% non-ionic contrast material divided into three
doses.
An initial unenhanced scan was obtained in all patients
starting from the level of the diaphragm down to the iliac crest
using a 5-mm slice thickness at 5-mm increments. An unen-
hanced scan demonstrates dense common bile duct calculi
and pancreatic calciﬁcations.
After the end of pre contrast CT examination, post contrast
scan was done. IV contrast medium (Ultravist 300 mg) was
injected at the rate of 4 ml per second using a power injector.
The contrast enhanced scans were obtained in a late arterial
phase (40s post-injection), and a portal venous phase
(70s post-injection). Contrast-enhanced acquisitions were
performed cranio-caudally with thin collimation (1 mm).
Table 4 TNM Classiﬁcation for the staging of pancreatic
cancer.25
Tumor (T)
TX Primary tumor not assessed
Tis Carcinoma in situ
T1 Tumor less than or equal to 2 cm in diameter and conﬁned to
the pancreas
T2 Tumor greater than 2 cm in diameter and conﬁned to the
pancreas
T3 Tumor extends beyond the pancreas but does not involve the
celiac axis or SMA
T4 Primary tumor involves either the celiac axis or the SMA
Node (N)
NX Regional lymph nodes not assessed
N0 No involvement of the regional lymph nodes
N1 Involvement of the regional lymph nodes
Metastases (M)
MX Distant metastases cannot be assessed
M0 No distant metastasis
M1 Distant metastasis
Figure 2 Irresectable pancreatic body adenocarcinoma T4N1
M1. Axial post contrast CT images (porto-venous phase) show
pancreatic body hypodense mass lesion inducing focal contour
bulge (white arrow) with loss of fat plane between it and the
Status of multi-detector row helical CT 9The pancreatic parenchymal phase provides excellent
enhancement of the arterial system. The portal venous phase
is ideal phase for detecting liver metastases, as well as for cre-
ating reconstructed images of the venous structures, which
might be essential for surgical planning.
2.3. The scan parameters and image analysis
The scan parameters were tube current 120 kV and 400 mA,
slice thickness 5 mm, collimation of 0.6 mm, pitch 0.6, 0.6-s
gantry rotation time and table speed of 7.5–10 mm per
rotation during a single breath-hold acquisition of 15–25 s.
Image interpretation was done on an independent worksta-
tion and included the axial source images and the reformatted
(MPR, MIP, CPR and volume rendering) images which helped
in the deﬁnition of the location and extent of the lesions. All
TDM was interpreted by the same radiologists working in pri-
vate radiology centers and in Ain Shams Specialized Hospital.
2.3.1. In cases of acute pancreatitis
The CT scan was assessed in case of non-enhancement and
normal enhancement pattern of pancreas. Non-enhancement
of pancreas represented pancreatic necrosis. The extent of pan-
creatic necrosis was estimated at 630%, more than 30% but
less than 50% and P50%.
CT scans were also assessed for peripancreatic inﬂamma-
tion, mesenteric stranding, peripancreatic ﬂuid collection,
pseudocyst, pancreatic abscess, and inﬂammatory changes of
the adjacent organs and vessels.
The severity of the pancreatitis for each case was assessed
using the CT severity index (CTSI) developed by Balthazar
et al. (Table 3). CTSI includes grading of pancreatitis (A–E)
and the extent of pancreatic necrosis. The maximum score that
can be obtained is 10.7
2.3.2. In cases of chronic pancreatitis
CT scans were assessed for intraductal calciﬁcations, main
pancreatic duct dilatation and parenchymal atrophy. It was
also assessed for any peri pancreatic collections and masses.
2.3.3. In cases of pancreatic neoplasm
Any pancreatic lesion was assessed according to tumor site,
size, and invasion of adjacent organs, CBD and pancreaticTable 3 CT severity index (CTSI) for grading of acute
pancreatitis by Balthazar et al.
CTSI
Grading of pancreatitis
 A: normal pancreas: 0
 B: enlargement of pancreas: 1
 C: inﬂammatory changes in pancreas and peripancreatic fat: 2
 D: ill-deﬁned single ﬂuid collection: 3
 E: two or more poorly deﬁned ﬂuid collections: 4
Pancreatic necrosis
 None: 0
 Less than/equal to 30%: 2
 >30–50%: 4
 >50%: 6
posterior wall of the stomach (thick arrow). There is also right
hepatic lobe hypodense metastatic focal lesion (thin curved black
arrow) and peri pancreatic nodal involvement (thin curved white
arrow). The distal pancreatic duct is seen dilated (thick curved
white arrow).ducts caliber, major vascular invasion, and lymph node
metastasis. Staging of the pancreatic mass was done accord-
ing to TNM system (Table 4). Classic criteria for deﬁning
non-resectability (Fig. 2) included extrapancreatic invasion
of adjacent tissues and organs other than the duodenum;
occlusion, stenosis, or semicircular encasement of any major
peripancreatic vessel (celiac, hepatic, or superior mesenteric
artery or portal or superior mesenteric vein); hepatic
metastases; peritoneal carcinomatosis; and lymph node or
distant metastases (Fig. 3).
Figure 3 Irresectable pancreatic body carcinoma (T4 N0M1).
Axial CT image shows hypodense heterogenous pancreatic body
mass (white arrow) encasing the celiac trunk (black arrow) and
atrophy of the pancreatic tail (arrowhead). Liver with multiple
hypodense lesions due to metastasis (thick black arrow).
Figure 4 Acute necrotizing pancreatitis CT SI 9. Note a ﬂuid
attenuation collection in the pancreatic bed with minute islands of
preserved fatty tissue (thin arrow) and well deﬁned rim, suggestive
of walled off necrosis with fat necrosis involving the pancreas and
peri pancreatic tissue. Few small areas of glandular enhancement
are only seen at the region of the body and tail (thick arrow).
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3.1. In case of pancreatitis
Eleven cases of pancreatitis were detected; eight patients were
diagnosed as acute pancreatitis (7 males and 1 female) and
three patients were diagnosed as chronic pancreatitis (2 male
and one female).
All cases of acute pancreatitis in our study were diagnosed
on the basis of the clinical data and elevated serum amylase.
The causes of acute pancreatitis in the 8 patients were as
follows: Gall Bladder stones (6 patients), alcohol (1 patient),
and idiopathic (1 patient).
Acute pancreatitis was graded by MSCT according to the
currently accepted CT severity index into 3 categories: Mild
(CT severity index 0–3), Moderate (CT severity index 4–6),
Severe (CT severity index 7–10) (Table 5).
Six patients showed complications resulting from acute
pancreatitis in the form of variable degrees of pancreatic
necrosis (Fig. 4). One patient showed pancreatic abscess
(Fig. 5), three patients showed pseudocysts (Fig. 6), three
patients complicated with organ failures, and one patient
showed sepsis. Percutaneous drainage of pancreatic pseudo-
cysts was performed in two patients. Percutaneous drainage
of an abscess was performed in one patient. Pseudocysts in
two patients showed spontaneous resolution during the course
of medical treatment for acute pancreatitis. The size of these
cysts did not exceed 5 cm in diameter.
3.2. Chronic pancreatitis
Three cases of chronic pancreatitis were diagnosed (2males and 1
female). Their age ranges from 45 to 60 years (mean, 52.5 years).
All patients had a history of repeated attacks of pancreatitis.Table 5 CT severity index in case of acute pancreatitis.
Category Number of patients Percentage (%)
Mild 2 25
Moderate 1 12.5
Severe 5 62.5Variable degrees of irregular and beaded pattern of
pancreatic duct dilatation were noted in all cases of chronic
pancreatitis. Pancreatic intraductal stones were observed in
two cases of the study. Pancreatic parenchymal atrophy was
present in all cases of chronic pancreatitis in this study. It
was graded as mild in two cases and moderate in one case.
Pancreatic calciﬁcation was detected in cases of chronic
pancreatitis with variable size (tiny stippled calciﬁcations to
large coarse calciﬁcations) and distribution from localized
involving one portion of the gland to diffusely distributed
(Fig. 7).
3.3. Neoplastic pancreatic lesions
This included 19 cases that were classiﬁed into two main
groups according to their pathological ﬁndings (Table 6):
1. Group I: Pancreatic adenocarcinoma.
2. Group II: Miscellaneous.
3.3.1. Group I (pancreatic adenocarcinoma)
This group included 14 patients, their age ranged from 50 to
72 years with a mean age of 62 years. Variable degrees of
MDCT ﬁndings are listed in Table 7.
Three patients showed ill-deﬁned heterogeneous focal
lesion in the pancreas, and one had peri pancreatic
lymphadenopathy. Three patients showed focal lesion of
heterogeneous echogenicity at the head of the pancreas
(Fig. 8), with dilatation of CBD, and/or intrahepatic biliary
radicles. Three patients showed only dilatation of CBD and
intrahepatic biliary radicles and the pancreatic area were
obscured by gases. Two patients showed focal lesion of
heterogeneous echogenicity at the pancreas, with dilatation
of intrahepatic biliary radicles, and hypoechoic focal lesions
of the liver. Two patients showed focal lesion of the pancreas
with hypoechoic areas of the liver (mostly metastatic).
Percutaneous CT guided biopsy was done in 4 patients,
intra-operative true-cut biopsy was done in 2 patients, percuta-
neous ultrasound guided biopsy was done in 2 patients and
(a) (b)
Figure 5 (a and b) Acute necrotizing pancreatitis with pancreatic necrosis and abscess formation. CTSI 10 Axial and coronal MDCT
images showed Fluid attenuation collection at the pancreatic body, tail and part of the head with well-deﬁned wall. It shows small fat
density (thin arrow) and air (thick arrow) loculi, suggestive of infected pancreatic walled off necrosis and abscess formation. Percutaneous
catheter is seen inside the collection for drainage.
Figure 6 Axial MDCT image showed Enlarged/swollen pan-
creas with patchy ill-deﬁned non enhancing areas of necrosis (thin
arrows) are seen at the pancreatic head, body and tail. There is
also stranding of the peri pancreatic fat and peri splenic ﬂuid
collection (thick arrow).
Figure 7 Chronic calciﬁc pancreatitis with intra ductal stone and
pseudopancreatic cyst. Axial CT images demonstrate atrophic
pancreas with innumerable diffuse calciﬁcation. A well-deﬁned
homogenous fully encapsulated collection, representing pseu-
dopancreatic cyst is seen related to the pancreatic head region
(curved arrow).
Table 6 Distribution of neoplastic pancreatic lesions accord-
ing to pathological ﬁndings.
Pathological diagnosis No. of cases Group
Pancreatic adenocarcinoma 14 I
Miscellaneous 5 II
19 Total
Table 7 The MDCT ﬁndings in pancreatic adenocarcinoma.
CT ﬁndings Number of
patients
Percentage
(%)
Intrahepatic biliary dilatation 6 42
Dilated pancreatic duct 6 42
Dilated CBD 6 42
Hepatic metastasis 7 50
Duodenal invasion 3 21
Enlarged lymph nodes 3 21
Ascites 2 14
Peri-pancreatic vascular
invasion
3 21
Chest lesions
Pulmonary
Deposits 4 28.5
Atelectatic bands 3 21
Pneumonic patches 2 14
Pleural eﬀusion 2 14
Osteolytic bone lesions 1 7
Status of multi-detector row helical CT 11ERCP biopsy was done in 6 patients. All fourteen patients
were proved to be adenocarcinoma by histopathological
examination.
Six cases that were suggested to be resectable by MDCT
criteria in our study proved to be surgically resectable intra
operative. However, surgical resection was aborted in only
one case out of 6 cases due to unsuspected peritoneal deposits.
(a) (b)
Figure 8 (a and b) Irresectable pancreatic head adenocarcinoma T4 N0M1. (a) Axial post contrast CT images (porto-venous phase)
pancreatic head heterogeneously enhancing irregular mass lesion inducing contour bulge (white arrow) invading the CBD with consequent
intra hepatic biliary dilatation (thin curved white arrow). There is also right hepatic lobe hypodense metastatic focal lesion (thin curved
black arrow). (b) Coronal MIP reconstruction clearly shows the vascular invasion of the portal vein.
Figure 9 Benign pancreatic head insulinoma. Axial CT cut
pancreatic-phase shows a 1 cm small, typically hyperenhancing
nodule in the pancreatic head (arrow).
Table 8 Classiﬁcation of patients according to resectability.
Resectability of the pancreatic adenocarcinoma
according to MSCT ﬁndings
Number of the
patients
Resectable group 6
Irresectable group 8
Total 14
12 M.Y. Tadros, R.Z. Elia3.3.2. Group II (miscellaneous)
This group included 5 patients with two patients were diag-
nosed as mucinous cystadenoma at the tail of the pancreas
by MSCT criteria. The two cases were females. The diagnosis
was conﬁrmed in one case by ultrasound guided aspiration
cytology and proved to be mucinous cystadenoma.
Follow-up was done in the other case and showed stationary
course.
One male patient showed pancreatic head irregular small
cystic lesion and MSCT diagnosis was pancreatic serous
cystadenoma. Follow-up was done after 6 months and showed
stationary course.
One female patient 45 years old presented with episodes of
hypoglycemia. MSCT showed hyper vascular well deﬁned
small lesion which enhanced more intensely than the normal
pancreatic parenchyma in all phases, and the ﬁnal diagnosis
was established as benign insulinoma (Fig. 9).
One female patient was diagnosed by MSCT as pancreatic
metastasis at the neck of the pancreas as well as at the
operative bed that showed the same pattern of enhancement.
She had a known history of right nephrectomy for renal cell
carcinoma. Biopsy from the operative bed revealed recurrent
renal cell carcinoma (see Table 8).4. Discussion
Imaging with CT had become a frontline technique for initial
diagnosis, evaluation of complications, and long-term
follow-up of a variety of diseases of the pancreas.8
Almost all life-threatening complications occur with necro-
tizing pancreatitis, including secondary bacterial contamina-
tion and multi-organ failure.9 In our study 2 patients showed
mild form of pancreatitis. In one patient (50%) ﬂuid collec-
tions were detected and resolved within one week. This agrees
with a study done by Lenhart and Balthazar10, in which ﬂuid
collections were detected in 73 patients (43.2%) and almost
totally resolved within 7–10 days in most patients.
No complications were detected in our study in the mild
form of acute pancreatitis. This is in contrary to the study done
by Lenhart and Balthazar10 who found Complications devel-
oped in nine patients with acute non necrotizing pancreatitis
with incidence of 5.3%.
The internationally accepted CT severity index, which is
based on scoring the presence and degree of pancreatic
inﬂammation and pancreatic necrosis, not only allows accurate
differentiation of mild from severe pancreatitis but also
numerically correlates with the patient’s prognosis.11
Our results conﬁrmed that the currently accepted CT sever-
ity index is indeed a powerful tool with which we can predict
morbidity in patients with acute pancreatitis. When comparing
patients with mild pancreatitis and those with severe pancreati-
tis, we documented a statistically signiﬁcant correlation
between the numeric score obtained with the currently
accepted index and the presence of infection, the need for
surgery and percutaneous interventions, and the length of
the hospital stay.
The reported mortality rate for patients with acute
pancreatitis varies greatly. A study by Casas12 demonstrated
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death. In Bradley’s study13, the CTSI > 8 is the index for
death. According to Simchuk et al.14, the CTSI < 3 had a
3% mortality rate, whereas patients with a CTSI > 7 had a
mortality rate of 17%. In our study, one patient out of the
eight patients died (12.5%) and had a CTSI = 10 and no
mortality was detected in mild and moderate form of acute
pancreatitis.
In our study we found that main pancreatic duct dilatation,
intra ductal calciﬁcation and variable degrees of pancreatic
atrophy were detected in all cases of chronic pancreatitis. Pan-
creatic pseudocyst was found in 33% of cases. This agreed with
Remer and Baker15 who found dilatation of the main pancre-
atic duct in 68% of patients, parenchymal atrophy in 54% of
patients, pancreatic calciﬁcations in 50% of patients, and ﬂuid
collections in 30% of patients.
In our work we used the pancreatic parenchymal phase and
the portal venous phase. Also Sahani et al.16 recommended the
same biphasic technique. 14 patients out of 19 had pancreatic
adenocarcinoma i.e. (75%) this comes in agreement with this
of Carbognin et al.17 who decided that ductal adenocarcinoma
accounts from 80% to 90% of all tumors of the pancreas.
8 male patients and 6 female patients had pancreatic
carcinoma and this was as the same as David’s et al. study18
which stated that higher rates of pancreatic carcinoma are seen
in men than in women and this is in contrast to John’s et al.19
who found that recently more women are developing
pancreatic malignancy.
Scaglione et al.20 reported that 60% of pancreatic tumors
occupied the head of pancreas, 10% the body, about 5% the
tail and the remaining 25% were diffusely involved. In our
study 57% of tumors occupied the head of the pancreas,
29% the body, and 14% the tail. That explains why 42% of
patients had a clinical history of jaundice because 57% of
the masses occupied pancreatic head.
The size of the pancreatic head tumors in our study was
between 2 and 4 cm and that was similar to Scaglione et al.20
who reported that at the level of the pancreatic head, the
average size was 2–3 cm.
Scaglione et al.20 stated that pancreatic carcinoma tended
to be hypo dense masses distorting pancreatic contour. In
our study 11 patients showed hypo dense lesions, while 3 cases
showed heterogeneous focal lesions.
In this study, the most common reported associated extra
pancreatic ﬁnding was dilated CBD and intra hepatic biliary
radical, which was seen in 6 patients (42%); this is seen in
75% of patients with head masses. John et al.19 stated that
ductal dilatation occurs in 58% of patients with pancreatic
neoplasm and ductal dilatation proximal to the obstructing
tumors was detected in approximately 88% of pancreatic head
tumors.
Liver metastases were detected by multi slice CT in 7
patients (50%). This comes in agreement with Murﬁtt21 who
stated that metastasis to the liver occurred in approximately
17–55% of the patients.
Chest distant metastatic ﬁnding was a common association
with pancreatic neoplasm in the current study. This was
reported in 28.5% of the patients. Osteolytic bony lesion was
found in 7%. This comes in agreement with the statement of
Kloppel22 who stated that metastasis to lung, pleura and bone
is only seen in advanced tumor stages.In our study, 5 cases were resectable out of 14 cases (35%).
Near to this is the study of Grenacher and KlauB23 which
stated that only 20% of all patients believed to have a surgi-
cally resectable disease.
Resection is aborted in one case out of 6 cases (about 16%
of the suspected resectable cases) due to unsuspected peri-
toneal deposits, whereas Zamboni et al.24 decided that resec-
tion was aborted in 11% of their suspected resectable cases.
Darren et al.25 stated that False-negative results almost
often occur because of the unsuspected liver surface metas-
tases, peritoneal deposits, or unsuspected vascular invasion.
Frate et al.26 stated thatMSCT has an accuracy rate for stag-
ing of pancreatic adenocarcinoma of virtually 100%. In our
study the overall accuracy of tumor staging by MSCT was
84%.WhereasZamboni et al.24 stated that the accuracies ranged
from85% to 95%, Scaglione et al.20 decided that the accuracy of
MSCT in staging of pancreatic cancer is as high as 93%.
In our study insulinoma appeared as well deﬁned small
lesion which enhanced more intensely than the normal pancre-
atic parenchyma in all phases. This coincides with McLean27
study which stated that insulinomas are typically hyper atten-
uating on at least one phase of contrast enhancement typically
on the late arterial [25 s] or pancreatic phase [35–40 s] of imag-
ing but occasionally in the portal venous phase.
In our study there were two cases of pathologically con-
ﬁrmed pancreatic mucinous cystadenoma. Both patients were
female and in relatively younger age group (53 and 57 years).
Aslam and Yee28 stated that a mucinous cystic neoplasm
occurs predominantly in women.
One case was diagnosed by MDCT as serous cystadenoma.
This was a 54 year old male. This is in contrast to Dewhurst
et al.29 who stated that about 80% occur in women who are
more than 60 years old. This is possibly attributed to small
number of cases enrolled in our study.
One case of pancreatic metastasis was from renal cell carci-
noma. Paspulati1 stated that the common primary tumors that
metastasize to the pancreas are from lung, breast, kidney, and
melanoma. Mecho´ et al.30 stated that pancreatic metastases are
uncommon, representing 4.5% of pancreatic tumors.
5. Conclusion
Contrast enhanced multiphase pancreatic imaging by MDCT
with its post processing techniques represents the imaging
modality of choice for diagnosis of different adult acquired
pancreatic disease.Conflict of interest
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